Target intelligence / Profile preview

HIV-1 envelope glycoprotein V3 glycan supersite (GDIR motif) (V3 glycan supersite)

Target
V3 glycan supersite
Molecular classification
Viral envelope glycoprotein, Surface protein, Lectin-binding site
01

Overview

The HIV-1 envelope glycoprotein V3 glycan supersite is a major site of vulnerability located at the base of the third variable (V3) loop of the gp120 subunit. It is characterized by a dense cluster of high-mannose glycans, most notably the N332 glycan, and a highly conserved underlying peptide motif known as GDIR (residues 324-327). This supersite is a primary target for several potent broadly neutralizing antibodies (bNAbs) that penetrate the viral glycan shield to bind both the carbohydrate and protein components. Biologically, this region is essential for viral entry as it facilitates the interaction between the HIV-1 envelope and host cell co-receptors, such as CCR5 or CXCR4. Therapeutic interventions, including passive immunization with bNAbs, target this site to neutralize the virus and prevent infection. However, the site is subject to therapeutic challenges such as viral escape through glycan shifting or mutations within the GDIR motif that confer resistance to specific antibodies.

Other names
GDIR motif324GDIR327 motifIR327 motifN332-supersiteV3 loop baseHigh-mannose patch
02

Mechanism of action

Broadly neutralizing antibodies bind to the V3 glycan supersite, specifically interacting with the N332 glycan and the conserved GDIR peptide motif, which sterically hinders the envelope glycoprotein from interacting with host co-receptors (CCR5 or CXCR4), thereby blocking viral entry and membrane fusion.

03

Biological functions

Viral entryMembrane fusionImmune evasionCo-receptor binding (CCR5/CXCR4)
04

Disease associations

Infection
05

Safety considerations

Viral escape via glycan shiftingPre-existing resistance mutations in the GDIR motifHigh sequence variability in the surrounding V3 loop regionsPolyclonal resistance development
06

Interacting drugs

10-1074

6 more in the full profile.

07

Biomarkers

N332 glycosylation site (PNGS at 332-334)GDIR motif sequence conservation (residues 324-327)

Beyond the preview

Go deeper on HIV-1 envelope glycoprotein V3 glycan supersite (GDIR motif) (V3 glycan supersite).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 envelope glycoprotein V3 glycan supersite (GDIR motif) (V3 glycan supersite).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call